REFERENCE RANGE: NEGATIVE
INTERPRETIVE CRITERIA: Negative : Antibody not detected
Positive: Antibody detected
PM-Scl antibody is detected in over 90% of patients with polymyositis (PM) and scleroderma (Scl) overlap syndrome, but only in about 8% of all myositis patients and only 3% of all scleroderma patients.